PrEP “Tremendously exciting” news of cabotegravir long-acting injectable for PrEP shared at AIDS 2020 By Emily Land, MA
PrEP High effectiveness and adherence to PrEP 2-1-1 in large San Francisco AIDS Foundation study By San Francisco AIDS Foundation
PrEP PrEP injectable found to be “highly effective” for HIV prevention in HPTN study By Emily Land, MA
PrEP New research: Is Descovy a new option for PrEP? By San Francisco AIDS Foundation and San Francisco AIDS Foundation
PrEP MSM in New York City: Low awareness, perceived effectiveness of U=U, and intermittent PrEP By Emily Land, MA
PrEP Strut evaluation report: More diversity, improved outcomes, and more room to grow By San Francisco AIDS Foundation and San Francisco AIDS Foundation
PrEP Hormone levels not affected by PrEP in trans women By Liz Highleyman and San Francisco AIDS Foundation
